# FDA Inspection 1127818 - Astellas Ireland Co., Ltd. - January 17, 2020

Source: https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/1e80cd1a-7004-489e-90b0-7f7f8e64a4b0
Source feed: FDA_Inspections

> FDA Inspection 1127818 for Astellas Ireland Co., Ltd. on January 17, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1127818
- Company Name: Astellas Ireland Co., Ltd.
- Inspection Date: 2020-01-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1271041 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/31d53ce9-08a4-4356-b61b-5615023b6886)
- [FDA Inspection 962296 - 2016-02-12](https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/6bb6b34e-6a5d-49f1-bc74-c35dda7e76bc)
- [FDA Inspection 853359 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/astellas-ireland-co-ltd/ef46a86f-f002-4400-839c-3363a590633a)

Company: https://www.keypedia.com/companies/astellas-ireland-co-ltd/9b0c01b3-245c-4559-a759-3aa95d1bc182

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c